Kopfbereich

additional navigation

Logo


Hauptinhalt

A Pioneer in Rare Diseases

AOP Orphan was one of the first companies to enter the sector of rare diseases in Europe and to this day, continues to be a trailblazer in the field of Orphan Diseases. As a specialist in Orphan Diseases, AOP Orphan researches, develops, produces, and distributes innovative solutions in the following therapeutic areas: hematology and oncology, cardiology and pulmonology, neurology and psychiatry, and metabolic diseases. Today AOP Orphan is active at an international scale with an export ratio of about 70% and has become a leading company in its home branch.

News

An interview with Dr Rudolf Widmann, CEO and Dr Christoph Klade, CSO about the current status of Vienna, Austria as a Research & Development base, its specifics,...


AOP Orphan Contact

AOP Orphan Romania

AOP Orphan worldwide

Products & Area of treatment